2004
DOI: 10.1111/j.1601-5215.2004.0076.x
|View full text |Cite
|
Sign up to set email alerts
|

Cholecystokinin and panic disorder

Abstract: Evidence for implication of cholecystokinin (CCK) in the neurobiology of panic disorder is reviewed through animal and human pharmacological studies. The results of these investigations raise two issues: (i) selectivity of action of CCK-2 agonists in anxiety disorders; and (ii) aberrations of the CCK system in anxiety disorders, both of which are discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 77 publications
1
2
0
Order By: Relevance
“…In the elevated T-maze, the same peptide markedly increased escape behavior while causing only a marginal facilitatory effect on inhibitory avoidance (Zanoveli et al, 2004). This effect on escape is in accordance with a wealth of evidence showing that agonists of CCK receptors induce panic attacks in healthy volunteers and in panic disorder patients (Bourin and Dailly, 2004).…”
Section: Discussionsupporting
confidence: 65%
“…In the elevated T-maze, the same peptide markedly increased escape behavior while causing only a marginal facilitatory effect on inhibitory avoidance (Zanoveli et al, 2004). This effect on escape is in accordance with a wealth of evidence showing that agonists of CCK receptors induce panic attacks in healthy volunteers and in panic disorder patients (Bourin and Dailly, 2004).…”
Section: Discussionsupporting
confidence: 65%
“…In contrast to the apparent general effects of COMT, the role of the CCK-B receptor gene seems to be implicated in a more specific way to PD (Hösing et al, 2004;Kennedy et al, 1999). There is ample evidence that cholecystokinin and the CCK-B receptor play a considerable role in the neurobiology in PD as described in animal studies, challenging studies, and genetic studies (Bourin and Dailly, 2004;Bradwejn and Koszycki, 2001). As the COMT variant as well as the CCK-B receptor CT repeat in the promoter region are associated with PD in Caucasians, the question arises as to whether PD is the result of a combination of general deficits, for example, COMT, or combined with specific ones, for example, cholecystokinin.…”
Section: Discussionmentioning
confidence: 99%
“…CCK is one of the most abundant neurotransmitter peptides in the brain and has been shown to induce excitation of central neurons as well as inhibitory post-synaptic effects (Bourin & Dailly 2004). CCK-1 and -2 receptors (G protein-coupled receptors) (recently reclassified as A and B) are widely distributed throughout the CNS.…”
Section: Neurochemistrymentioning
confidence: 99%